Anew Labs
PulseAugur coverage of Anew Labs — every cluster mentioning Anew Labs across labs, papers, and developer communities, ranked by signal.
3 day(s) with sentiment data
-
ByteDance spin-off Anew Labs raises $290M for AI drug discovery
Anew Labs, a former unit of ByteDance, has secured US$290 million in funding at a US$1.5 billion valuation. The Shanghai-based AI drug discovery firm's funding round was backed by prominent venture capital firms includi…
-
OpenAI in talks for $1.2T funding; ByteDance spins off AI drug unit
OpenAI is reportedly in talks to secure new funding that could value the company at over $1.2 trillion. In other tech news, ByteDance has completed a $290 million funding round for its AI drug discovery subsidiary, Anew…
-
Anew Labs secures $290M in Series A funding from top VCs
Anew Labs, an AI-focused pharmaceutical company, has successfully closed its inaugural independent funding round, securing $290 million. The financing round saw participation from prominent investors including Sequoia C…
-
ByteDance spins off AI drug discovery unit for independent funding
ByteDance is spinning off its AI drug discovery division to pursue independent financing, while retaining majority control. This move aims to establish a more suitable organizational structure for the AI for Science (AI…
-
ByteDance's Anew Labs presents AI-designed therapies at global conferences
ByteDance's Anew Labs, a drug discovery division, is now presenting AI-designed therapies at global conferences. The unit, with operations in Shanghai, Singapore, and San Jose, has showcased generative AI treatments for…